toray inds inc, Mitsubishi Gas, etc (additional) Rating
Upgrade - bullish code stock name securities company conventional change after -----------------------------------------------------------<5021> Cosmo Energy HD Mizuho "hold" "buy" <8985> JHR City "2" "1" <9025> Konoike Transportation Daiwa "3" "2" <9107> Kawasaki Ship JPM "Neutral" "Over W" Downgrade - bearish code stock name securities company conventional change after -----------
List of Cloud Break Stocks (Part 4) [Ichimoku Kinko Hyo, List of Cloud Break Stocks]
○ List of stocks below the clouds market Code Stock Name End Price Leading Span A Leading Span B Tokyo Main Board <6861> Keyence 64000 67647.5 65410 <6866> HIOKI 7600 82057715 <6937> Furukawa Battery 1366 1378.25 1372.5 <6954> Fanuc Corp 3973 4068.75 4090 <7173> Tokyo Kiraboshi 4100 4243.7
Sumitomo Corporation, Komatsu, etc. [List of stock-related news from newspapers]
Sumitomo Corporation <8053> Sumitomo Precision Industries, expanding MEMS contract manufacturing, acquiring US joint venture (Nikkan Sangyo front page) - koss corp Energy HD <5021> Cosmo Petroleum, with JGC HD and others, mass production of SAF in Sakai, trial gold supply (Nikkan Sangyo page 3) - koss corp Energy HD <1963> In partnership with Sakai City and 4 others, agreement on waste cooking oil collection, supplying raw materials to SAF production plant (Nikkan Sangyo page 3) - Dentsu <2433> Sekisui House, security services reflected in fees, promoting crime prevention habits (Nikkan Sangyo page 3) -
Outperforming the large cap of the US stock market and 97% of peers! How to select stocks for this emerging markets fund.
Cusana Capital LLP's emerging markets fund managed by founding partner and chief investment officer Rob Marshall-Lee has seen a 37% increase in the past 12 months, outperforming 97% of its peers.
The Nikkei average fell significantly, weighed down by the decline in tech stocks.
Last weekend, the Dow Jones Industrial Average in the USA market closed with a loss of 305.87 points at 43444.99 points, while the NASDAQ closed with a loss of 427.53 points at 18680.12 points. The selling pressure continued following hawkish remarks by Federal Reserve Chair Powell, leading to a decline after the opening. Buying interest, which was driven by expectations of policies supporting corporate performance such as deregulation by the upcoming Trump administration, paused. Furthermore, the speculation of an additional rate cut in December receded after comments from Fed officials, contributing to the continued decline. US stocks that declined.
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
Scorpio Tankers Analyst Ratings
Reasons why the US military has no choice but to "ride along" with commercial ships.
It has been reported that US military combat units need assistance with trucking. Since the end of last year, briefings regarding combat operations in the Red Sea have been held here every two weeks, attended by executives from civilian marine shipping companies. The aircraft and cargo ships of the US Transportation Command are aging and their capabilities are insufficient. Of the 44 government-owned vehicle transport ships available to the Transportation Command, 28 are set to retire within eight years, and the deployment of replacement vessels seems to have faced multiple delays.
Jefferies Maintains Buy on Danaos, Maintains $105 Price Target
Danaos Analyst Ratings
Danaos Non-GAAP EPS of $6.50 Misses by $0.28, Revenue of $256.18M Misses by $1.82M
Nippon Yusen Kabushiki Kaisha (NPNYY) Q2 2024 Earnings Call Transcript Summary
Shipping Markets Hit YTD Lows, Led by Tankers and Gas Carriers - Clarksons
CERo Therapeutics Presents Preclinical Data At SITC 2024 Showing CER-1236 Effectively Kills Ovarian Cancer Cells Without Toxicity In Animal Models
Compass Therapeutics Presents Biomarker Data Related To CTX-471 Clinical Activity At SITC Annual Meeting
Mural Oncology Presents Data Across Its Pipeline At 39th SITC Annual Meeting
Nektar And Collaborators Present Late-Breaking Results From Phase 2 Study Of NKTR-255 For The Treatment Of Radiation Induced Lymphopenia In Locally Advanced Non-Small Cell Lung Cancer Patients At SITC Annual Meeting; Demonstrated Statistically...
Agenus To Present Data On Botensilimab And AGEN1721 At SITC 2024; Novel Candidates Show Promise In Turning Cold And Refractory Tumors Into Responsive Targets
MiNK's INKT Cell Therapy Shows Potential For Optimal Multi-Combination For Resistant Solid Cancers At SITC 2024; PRAME-TCR INKT Overcomes Challenges From Conventional TCR-T Cells In Solid Cancers